Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.148
+0.020 (1.77%)
At close: Jun 11, 2026
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 174.82 million as of June 11, 2026. Its market cap has decreased by -86.06% in one year.
Market Cap
174.82M
Enterprise Value
-15.91M
Revenue
362.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 174.82M, an increase of 31.93%. That is a compound annual growth rate of 2.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 177.92M | -88.51% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 228.19M |
| Xbrane Biopharma AB | 212.24M |
| Initiator Pharma | 184.82M |
| Xintela AB | 172.25M |
| Elicera Therapeutics AB | 169.51M |
| Active Biotech AB | 167.92M |
| Nanologica AB | 167.02M |
| AlzeCure Pharma AB | 159.16M |